Inspections, Compliance, Enforcement, and Criminal Investigations
Reed's Inc - Close Out Letter 12/11/2012
| Public Health Service Food and Drug Administration |
| Los Angeles District Pacific Region 19701 Fairchild Irvine, CA 92612-2506 Telephone: 949-608-2900 FAX: 949-608-4415 |
VIA UNITED PARCEL SERVICE
SIGNATURE REQUIRED
December 11, 2012
Mr. Christopher J. Reed, CEO
Reed's Inc
13000 S. Spring St.
Los Angeles, CA 90061
Dear Mr. Reed:
The Food and Drug Administration has completed an evaluation of your corrective actions in response to our Warning Letter, WL # 43-11, dated 05/19/11. Based on our inspectional evaluation and your written responses, it appears that you have addressed the violation(s) contained in the Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
Alonza E. Cruse, Director
Los Angeles District





Department of Health and Human Services

